Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 1999. Start Trial.
Date Value
May 31, 2026 -3.422M
February 28, 2026 -3.189M
November 30, 2025 -2.969M
August 31, 2025 -2.802M
May 31, 2025 -3.878M
February 28, 2025 -4.285M
November 30, 2024 -5.053M
August 31, 2024 -5.083M
May 31, 2024 -5.476M
February 29, 2024 -5.385M
November 30, 2023 -5.299M
August 31, 2023 -5.682M
May 31, 2023 -5.552M
February 28, 2023 -8.857M
November 30, 2022 -4.786M
August 31, 2022 -2.256M
May 31, 2022 -0.6508M
February 28, 2022 2.552M
November 30, 2021 -1.252M
August 31, 2021 -3.859M
May 31, 2021 -5.547M
February 28, 2021 -8.030M
November 30, 2020 -7.032M
August 31, 2020 -6.084M
May 31, 2020 -4.416M
Date Value
February 29, 2020 -1.893M
November 30, 2019 -1.716M
August 31, 2019 -1.620M
May 31, 2019 -2.415M
February 28, 2019 -1.755M
November 30, 2018 -1.974M
August 31, 2018 -1.977M
May 31, 2018 -1.304M
February 28, 2018 -1.260M
November 30, 2017 -0.9016M
August 31, 2017 -0.8917M
May 31, 2017 -0.819M
February 28, 2017 -0.5232M
November 30, 2016 -0.1833M
August 31, 2016 -0.1746M
May 31, 2016 -0.304M
February 29, 2016 -0.3544M
November 30, 2015 -1.046M
August 31, 2015 -0.7574M
May 31, 2015 -0.416M
February 28, 2015 -0.3568M
November 30, 2014 -0.0001M
August 31, 2014 -0.4746M
May 31, 2014 -0.9995M
February 28, 2014 -1.08M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Univec, Inc. -15.55M
Lantheus Holdings, Inc. 382.42M
Zomedica Corp. -14.80M
IDEXX Laboratories, Inc. 1.233B
Neogen Corp. 31.90M